KDA Group Net Debt per Share
Net Debt per Share of KDA Group (KDA.V) as of Oct 26, 2026.
Get this data via API
Financial Data API
Net Debt per Share
0.00CAD
YoY
-85.08%
Last updated:
Net Debt per Share of KDA Group is 2024 0.00 CAD. Net Debt per Share of KDA Group was 2023 0.02 CAD. It decreases by -85.08% lower compared to the previous year.
The KDA Group Net Debt per Share history
3 Years
10 Years
25 Years
Max
Net Debt per Share
Date
Net Debt per Share
Jan 1, 2016
0.04 CAD
Jan 1, 2017
0.12 CAD
Jan 1, 2018
0.08 CAD
Jan 1, 2019
0.05 CAD
Jan 1, 2020
0.00 CAD
Jan 1, 2021
0.03 CAD
Jan 1, 2022
0.02 CAD
Jan 1, 2024
0.00 CAD
| YEAR | Net Debt per Share | YoY |
|---|---|---|
| 0.00CAD | -85.08% | |
| 0.02CAD | -21.93% | |
| 0.03CAD | +1,009.36% | |
| 0.00CAD | -94.28% | |
| 0.05CAD | -45.11% | |
| 0.08CAD | -31.03% | |
| 0.12CAD | +236.52% | |
| 0.04CAD | +18.44% | |
| 0.03CAD | +1,548.95% | |
| 0.00CAD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
KDA Group Stock analysis
What does KDA Group do? KDA Group, Inc. generates revenue through its Pharmacy Services, Pharmaceutical Solutions, and Pharmaceutical Technology segments. The Pharmacy Services segment provides training, consulting, and replacement services for healthcare professionals. The Pharmaceutical Solutions segment develops and integrates technological platforms for healthcare professionals. The Pharmaceutical Technology segment offers KRX, KRX DENTAL, and ADRX platforms, while ZRx Digital Prescriber is an electronic prescriber software for authorized healthcare providers. Subsidiaries like Alliance Pharma Operations Inc. and Elitis Pharma Inc. support these services.
Clients include healthcare professionals who require training, consulting, and technological solutions. The Pharmacy Services segment targets professional resource needs in healthcare, while Pharmaceutical Solutions and Technology segments serve healthcare professionals with integrated platforms and digital tools. Subsidiaries such as Logistik Pharma Inc. and Groupe Technologique KDA Inc. contribute to the company's service delivery.
Pharmaceutical Technology platforms like KRX, KRX DENTAL, and ADRX are sold to healthcare professionals seeking digital solutions. ZRx Digital Prescriber is utilized by authorized prescribers for medication and treatment management. The company's subsidiaries operate within the segments to deliver specialized services, ensuring comprehensive solutions for healthcare providers. KDA Group is one of the most popular companies on Eulerpool.
Frequently Asked Questions about KDA Group stock
On Eulerpool you can find the complete historical development of Net Debt per Share KDA Group since 2006 – with annual values, charts, and detailed analysis.
Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Other — KDA Group
All Key Metrics — KDA Group
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth